Federal contract award

70RSAT19CB0000025

OBTAIN HIGHLY SPECIALIZED TECHNICAL RESEARCH, DEVELOPMENT AND DELIVERY CAPABILITIES

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Homeland Security
OfficeSCI TECH ACQ DIV
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAZ11 — OTHER RESEARCH AND DEVELOPMENT - BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$20.9M
Current contract value$21.1M
Potential contract value / ceiling$21.1M
Start dateOct 1, 2019
Current end dateJan 24, 2025
Potential end dateJan 24, 2025
Latest award activityJul 27, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 16 of 16 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 27, 2026P00015$-449.2KTHE PURPOSE OF MODIFICATION P00015 IS TO DEOBLIGATE UNEXPENDED FUNDING AND CLOSEOUT THE CONTRACT
Dec 11, 2024P00014$0NO COST EXTENSION
Oct 24, 2024P00013$0FUNDING REALIGNMENT
Apr 10, 2024P00012$2.8MADDITIONAL WORK WITHIN SCOPE
Sep 15, 2023P00011$759.0KINCREMENTALLY FUND OPTION PERIOD 3
Aug 8, 2023P00010$500.0KINCREMENTALLY FUND OPTION PERIOD 3
Jun 7, 2023P00009$2.9MEXERCISE AND INCREMENTALLY FUND OPTION PERIOD 3
Apr 18, 2023P00008$2.1MFULLY FUND OPTION PERIOD 2
Jun 28, 2022P00007$3.5MOPTION PERIOD 2 EXERCISE
Nov 9, 2021P00006$0BILATERAL NO-COST ADMINISTRATIVE MODIFICATION IS TO INCORPORATE FAR CLAUSE 52.223.-99.
Aug 17, 2021P00005$2.2MMODIFICATION (MOD #5) TO 70RSAT19CB0000025.
May 18, 2021P00004$2.3MTHE PURPOSE OF THIS UNILATERAL MODIFICATION IS TO EXERCISE OPTION PERIOD I, CLIN 1001; PARTIALLY FUND OPTION PERIOD I, CLIN 1001 IN THE AMOUNT OF $2,295,000.00.
Sep 4, 2020P00003$500.0KTHE PURPOSE OF THIS BILATERAL MODIFICATION IS TO PARTIALLY FUND OPTIONAL CLIN 0003 IN THE AMOUNT OF $500,000; EXTEND THE BASE PERIOD PERFORMANCE PERIOD; AND TO REVISE THE PERFORMANCE PERIODS FOR OPTION PERIOD I THROUGH OPTION PERIOD III.
Jun 25, 2020P00002$200.0KTHE PURPOSE OF THIS MODIFICATION IS TO PARTIALLY FUND CLIN 0003.
May 15, 2020P00001$1.9MOBTAIN HIGHLY SPECIALIZED TECHNICAL RESEARCH, DEVELOPMENT AND DELIVERY CAPABILITIES
Sep 30, 20190$1.7MOBTAIN HIGHLY SPECIALIZED TECHNICAL RESEARCH, DEVELOPMENT AND DELIVERY CAPABILITIES

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.